iCMLf Knowledge Centre

eLearning for Clinicians, Molecular Biologists, & Pathologists

iCMLf Knowledge Center

 

Diary Dates

Save the date for important iCMLf meetings and programs
calendar

Become a member

Become an iCMLf member - help shape our future
member-button

Please donate

Support our activities
by donating
Donate here

Supporters

We thank all our supporters and partners

 

If you are not a member, please click on "Register". If you have forgotten your password, please click on "Forgot login?" below.

EU e-Privacy Directive

CML Expert Opinions

        

Importance of Molecular Monitoring in CML: How Deep, How Often, and How Should it Influence Therapy?
Professor Timothy Hughes
Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia

Tim Hughes explored the appropriate time-dependent molecular targets for CML patients on TKI and the reasons why those targets differ, especially when considering treatment discontination. He also discussed the facts that influence the choice of TKI when molecular responses are not optimal and highlighted the critical role of molecular monitoring in managaging treatment-free remission.   


Comments closed!